Workflow
*ST大立(002214) - 002214*ST大立投资者关系管理信息20250506
DALI TECHDALI TECH(SZ:002214)2025-05-06 10:52

Group 1: Company Performance and Financials - The company has signed a contract for a certain optical system with a value of 71 million RMB, which is expected to enhance its equipment business development space [3] - The company aims to achieve a sales revenue target of 500 million RMB for the year, supported by identified projects and sales target agreements [5] - As of the end of 2024, the company has a cash balance of 108 million RMB, with most bank loans being medium to long-term credit loans [19] - The company has accumulated a credit loss provision of 305.017 million RMB, which will be adjusted upon recovery of receivables [8] Group 2: Research and Development - The company invests heavily in R&D, with R&D personnel salaries and benefits accounting for 65.67% of R&D expenses [11] - The new optical base is expected to have an annual production capacity of 200 complex optical systems and 1,800 optical products, aiming for over 3 billion RMB in revenue [12][25] - The company has developed several optical turret products for various platforms, including drones and ships, to meet diverse operational needs [10][37] Group 3: Market and Product Development - The company has established partnerships with several domestic enterprises in the drone and unmanned boat sectors, showing positive progress [26] - The company is focusing on expanding its market presence in infrared products for personal consumption and power monitoring applications [52] - The company is actively participating in equipment research project bidding and has achieved breakthroughs in multiple fields [9] Group 4: Challenges and Strategies - The company plans to reverse its losses through enhanced marketing, increased receivables collection, and strict cost control [48] - The company has faced challenges with delayed orders leading to high inventory turnover days [35] - The company is committed to maintaining transparency and compliance with legal regulations, denying any allegations of financial misconduct [60]